[ad_1] <br><a href="https://news.google.com/rss/articles/CBMinwFodHRwczovL3NpbXBseXdhbGwuc3Qvc3RvY2tzL2luL3BoYXJtYWNldXRpY2Fscy1iaW90ZWNoL25zZS1nbHMvZ2xlbm1hcmstbGlmZS1zY2llbmNlcy1zaGFyZXMvbmV3cy9nbGVubWFyay1saWZlLXNjaWVuY2VzLW5zZWdscy1qdW1wcy0xNC10aGlzLXdlZWstdGhvdWdoLWVhcm7SAaMBaHR0cHM6Ly9zaW1wbHl3YWxsLnN0L3N0b2Nrcy9pbi9waGFybWFjZXV0aWNhbHMtYmlvdGVjaC9uc2UtZ2xzL2dsZW5tYXJrLWxpZmUtc2NpZW5jZXMtc2hhcmVzL25ld3MvZ2xlbm1hcmstbGlmZS1zY2llbmNlcy1uc2VnbHMtanVtcHMtMTQtdGhpcy13ZWVrLXRob3VnaC1lYXJuL2FtcA?oc=5" target="_blank" rel="noopener">Glenmark Life Sciences (NSE:GLS) jumps 14% this week, though earnings growth is still tracking behind one-year shareholder returns</a> <font color="#6f6f6f">Merely Wall St</font> <br>[ad_2] <br><a href="https://news.google.com/rss/articles/CBMinwFodHRwczovL3NpbXBseXdhbGwuc3Qvc3RvY2tzL2luL3BoYXJtYWNldXRpY2Fscy1iaW90ZWNoL25zZS1nbHMvZ2xlbm1hcmstbGlmZS1zY2llbmNlcy1zaGFyZXMvbmV3cy9nbGVubWFyay1saWZlLXNjaWVuY2VzLW5zZWdscy1qdW1wcy0xNC10aGlzLXdlZWstdGhvdWdoLWVhcm7SAaMBaHR0cHM6Ly9zaW1wbHl3YWxsLnN0L3N0b2Nrcy9pbi9waGFybWFjZXV0aWNhbHMtYmlvdGVjaC9uc2UtZ2xzL2dsZW5tYXJrLWxpZmUtc2NpZW5jZXMtc2hhcmVzL25ld3MvZ2xlbm1hcmstbGlmZS1zY2llbmNlcy1uc2VnbHMtanVtcHMtMTQtdGhpcy13ZWVrLXRob3VnaC1lYXJuL2FtcA?oc=5">Source link </a>
